Product Images Rivaroxaban

This text provides information on a medication containing 2.5 mg of rivaroxaban, USP. The usual dosage and storage instructions are included. It also mentions the manufacturer, ScieGen Pharmaceuticals, Inc., and provides a link to print the Medication Guide. The medication is in tablet form, with 180 tablets in the pack. The National Drug Code (NDC) for this medication is 50228-513-18. It emphasizes that the Medication Guide should be dispensed to each patient.*

This text appears to be a table showing the Cumulative Incidence Rate (%) over days from randomization for a study comparing a placebo group with a treatment group. The data includes the number of subjects studied for each time point.*

This text provides a description of the population characteristics, including information on different health conditions such as end-stage renal disease and renal impairment, along with age ranges, body weight categories, and hepatic impairment levels. Additionally, it presents fold change and 90% confidence intervals for certain conditions.*

This text provides data on a clinical trial comparing the effects of Rivaroxaban (a medication) versus a Placebo. The table shows the Cumulative Incidence Rate (%) and Hazard Ratio with 95% confidence intervals. It also lists the number of subjects at risk for each group over the course of the trial in days from randomization. The information suggests that Rivaroxaban may have an impact on the incidence rate compared to the placebo.*

Each tablet contains 2.5 mg of rivaroxaban, USP. The usual dosage and storage instructions are provided. The medication is manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY, with 60 tablets in a pack. The Medication Guide can be printed from the given website. It is important to keep the medication out of reach of children. Each patient should be dispensed the accompanying Medication Guide. It is for prescription use only.*